Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
Medivation, Inc.
The main purpose for this study is to determine whether dimebon exhibits abuse potential.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Healthy male and/or female subjects between the ages of 18 and 55 years.
Recreational polydrug user with a history of CNS depressant use.
You may not be if
History of clinically significant neurologic condition(s), such as seizures, convulsions, epilepsy, or significant head injury, as judged by the investigator or designee.
A known history of hypersensitivity or previous intolerance to dimebon or other antihistamines.
Self-reported history of drug or alcohol dependence (except nicotine or caffeine) in the 2 years prior to screening, or drug or alcohol dependence as defined by the (DSM-IV-TR) in 12 months prior to screening, including subjects who have ever been in a substance rehabilitation program (other than treatment for smoking cessation).
History of clinically significant psychiatric disorder(s), as judged by the investigator or qualified designee.
